Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-07-08FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for a generic ondansetron hydrochloride product submitted by Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Effects of Antiemetic Agents in Orthognathic Surgery Patients [Phase 4]
Phase 4 clinical trial update evaluating antiemetic drugs for managing postoperative nausea and vomiting in patients undergoing orthognathic…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Sugammadex and Neostigmine in Pediatric Patients
A completed pediatric trial comparing sugammadex and neostigmine for postoperative recovery. The study examined outcomes including postopera…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONV [Phase 2]
Phase 2 trial comparing dexamethasone with ondansetron versus dexamethasone with haloperidol to reduce postoperative nausea and vomiting in …
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Impact of Intrathecal vs Intravenous Dexmedetomidine [Phase 4]
Phase 4 trial comparing intrathecal versus intravenous dexmedetomidine for postoperative nausea and vomiting; recruitment not yet started.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Effect of Pulmonary Recruitment Maneuver (PRM) on Pain and Nausea After Laparoscopic Cholecystectomy [NA]
This completed clinical trial evaluated whether Pulmonary Recruitment Maneuver reduces postoperative pain and postoperative nausea and vomit…
-
FDA approval · 2024-05-06FDA Approved: SCOPOLAMINE — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved Rhodes Pharmaceuticals L.P.'s original application for scopolamine (generic), enabling marketing of a scopolamine product.
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Comparison of the Efficacy of Acupressure P6 Point, Dexamethasone and Ondansetron Versus Palonosetron Monotherapy for Preventing Postoperative Nausea and Vomiting in Laparoscopic Surgery [NA]
Completed clinical trial comparing acupressure at the P6 point with dexamethasone and ondansetron versus palonosetron monotherapy for preven…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: The Role of High Intraoperative Fraction of Inspired Oxygen in Preventing Postoperative Nausea and Vomiting
The study evaluates whether using a high intraoperative fraction of inspired oxygen reduces postoperative nausea and vomiting after laparosc…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Effect of Stellate Ganglion Block on Postoperative Nausea and Vomiting [NA]
This clinical trial assesses whether stellate ganglion block reduces postoperative nausea and vomiting in patients undergoing thyroid surger…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Oral Carbohydrates in Pediatric Surgery and Random Blood Glucose Level [NA]
Cairo University is conducting a clinical trial to evaluate oral carbohydrates in pediatric surgery and its effect on postoperative nausea a…
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting [Phase 4]
Phase 4 trial update for HSK21542 injection evaluating its economic impact in preventing postoperative nausea and vomiting; currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy. [Phase 2, Phase 3]
A Phase 2/3 trial evaluating whether perioperative dexamethasone reduces postoperative pain after periacetabular osteotomy.
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Naldebain and Video-assisted Thoracoscopic Surgery [Phase 4]
Phase 4 clinical trial update for Naldebain in the context of postoperative analgesia and nausea/vomiting after thoracoscopic surgery; curre…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Oral Dexamethasone for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy [Phase 3]
Phase 3 trial evaluating oral dexamethasone for postoperative nausea and vomiting after laparoscopic cholecystectomy.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Anesthetic Premedication With a Cannabis Extract (Cannapremed) [Phase 2, Phase 3]
Phase 2/3 trial update on Cannapremed, an anesthetic premedication using a cannabis extract, with conditions including postoperative pain, p…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy [Phase 4]
Phase 4 trial update on prevention and management of postoperative nausea and vomiting in patients undergoing laparoscopic sleeve gastrectom…
-
FDA approval · 2024-01-31FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc., indicating an approved change to the generic's la…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Gynecologic Endoscopic Surgery of Female Motion Sickness Patients [Phase 4]
Phase 4 clinical trial update related to gynecologic endoscopic surgery in motion sickness patients, completed.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy [Phase 2, Phase 3]
A phase 2/3 clinical trial comparing dexamethasone given at night versus at induction for postoperative nausea and vomiting after laparoscop…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients [Phase 4]
A Phase 4 clinical trial update on remimazolam for postoperative nausea and vomiting in high-risk patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Satisfactory Analgesia Minimal Emesis in Day Surgeries [NA]
A completed clinical trial evaluating satisfactory analgesia and minimal emesis in day surgeries; results have been posted.
-
FDA approval · 2023-10-27FDA Approved: SCOPOLAMINE TRANSDERMAL SYSTEM — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Scopolamine Transdermal System submitted by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2023-10-12FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Granisetron Hydrochloride by Bionpharma Inc., a generic antiemetic used to prevent chemotherapy-…
-
FDA approval · 2023-09-26FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
FDA granted a supplemental approval for Ondansetron hydrochloride from Eugia US LLC, updating the status of this generic product. The action…